34084141|t|D-Amphetamine Rapidly Reverses Dexmedetomidine-Induced Unconsciousness in Rats.
34084141|a|D-amphetamine induces emergence from sevoflurane and propofol anesthesia in rats. Dexmedetomidine is an alpha2-adrenoreceptor agonist that is commonly used for procedural sedation, whereas ketamine is an anesthetic that acts primarily by inhibiting NMDA-type glutamate receptors. These drugs have different molecular mechanisms of action from propofol and volatile anesthetics that enhance inhibitory neurotransmission mediated by GABAA receptors. In this study, we tested the hypothesis that d-amphetamine accelerates recovery of consciousness after dexmedetomidine and ketamine. Sixteen rats (Eight males, eight females) were used in a randomized, blinded, crossover experimental design and all drugs were administered intravenously. Six additional rats with pre-implanted electrodes in the prefrontal cortex (PFC) were used to analyze changes in neurophysiology. After dexmedetomidine, d-amphetamine dramatically decreased mean time to emergence compared to saline (saline:112.8 +- 37.2 min; d-amphetamine:1.8 +- 0.6 min, p < 0.0001). This arousal effect was abolished by pre-administration of the D1/D5 dopamine receptor antagonist, SCH-23390. After ketamine, d-amphetamine did not significantly accelerate time to emergence compared to saline (saline:19.7 +- 18.0 min; d-amphetamine:20.3 +- 16.5 min, p = 1.00). Prefrontal cortex local field potential recordings revealed that d-amphetamine broadly decreased spectral power at frequencies <25 Hz and restored an awake-like pattern after dexmedetomidine. However, d-amphetamine did not produce significant spectral changes after ketamine. The duration of unconsciousness was significantly longer in females for both dexmedetomidine and ketamine. In conclusion, d-amphetamine rapidly restores consciousness following dexmedetomidine, but not ketamine. Dexmedetomidine reversal by d-amphetamine is inhibited by SCH-23390, suggesting that the arousal effect is mediated by D1 and/or D5 receptors. These findings suggest that d-amphetamine may be clinically useful as a reversal agent for dexmedetomidine.
34084141	0	13	D-Amphetamine	Chemical	MESH:D003913
34084141	31	46	Dexmedetomidine	Chemical	MESH:D020927
34084141	55	70	Unconsciousness	Disease	MESH:D014474
34084141	74	78	Rats	Species	10116
34084141	80	93	D-amphetamine	Chemical	MESH:D003913
34084141	117	128	sevoflurane	Chemical	MESH:D000077149
34084141	133	141	propofol	Chemical	MESH:D015742
34084141	156	160	rats	Species	10116
34084141	162	177	Dexmedetomidine	Chemical	MESH:D020927
34084141	269	277	ketamine	Chemical	-
34084141	423	431	propofol	Chemical	MESH:D015742
34084141	436	456	volatile anesthetics	Chemical	-
34084141	573	586	d-amphetamine	Chemical	MESH:D003913
34084141	631	646	dexmedetomidine	Chemical	MESH:D020927
34084141	651	659	ketamine	Chemical	-
34084141	669	673	rats	Species	10116
34084141	831	835	rats	Species	10116
34084141	952	967	dexmedetomidine	Chemical	MESH:D020927
34084141	969	982	d-amphetamine	Chemical	MESH:D003913
34084141	1075	1092	d-amphetamine:1.8	Chemical	-
34084141	1181	1204	D1/D5 dopamine receptor	Gene	25195
34084141	1217	1226	SCH-23390	Chemical	MESH:C534628
34084141	1234	1242	ketamine	Chemical	-
34084141	1244	1257	d-amphetamine	Chemical	MESH:D003913
34084141	1354	1372	d-amphetamine:20.3	Chemical	-
34084141	1462	1475	d-amphetamine	Chemical	MESH:D003913
34084141	1572	1587	dexmedetomidine	Chemical	MESH:D020927
34084141	1598	1611	d-amphetamine	Chemical	MESH:D003913
34084141	1663	1671	ketamine	Chemical	-
34084141	1689	1704	unconsciousness	Disease	MESH:D014474
34084141	1750	1765	dexmedetomidine	Chemical	MESH:D020927
34084141	1770	1778	ketamine	Chemical	-
34084141	1795	1808	d-amphetamine	Chemical	MESH:D003913
34084141	1850	1865	dexmedetomidine	Chemical	MESH:D020927
34084141	1875	1883	ketamine	Chemical	-
34084141	1885	1900	Dexmedetomidine	Chemical	MESH:D020927
34084141	1913	1926	d-amphetamine	Chemical	MESH:D003913
34084141	1943	1952	SCH-23390	Chemical	MESH:C534628
34084141	2056	2069	d-amphetamine	Chemical	MESH:D003913
34084141	2119	2134	dexmedetomidine	Chemical	MESH:D020927
34084141	Negative_Correlation	MESH:C534628	MESH:D003913
34084141	Positive_Correlation	MESH:D020927	MESH:D014474
34084141	Negative_Correlation	MESH:D003913	MESH:D020927
34084141	Negative_Correlation	MESH:C534628	25195
34084141	Negative_Correlation	MESH:D003913	MESH:D014474

